Rapid Micro Biosystems (RPID) Return on Capital Employed (2021 - 2026)

Rapid Micro Biosystems has disclosed Return on Capital Employed across 6 years of filings, most recently posting 100.19% for Q1 2026.

• Return on Capital Employed for Q1 2026 came in at 100.19%, down 3860.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 100.19% (down 3860.0% YoY), and the FY2025 annual result was 69.67%, down 2132.0% from the prior year.
• Return on Capital Employed came in at 100.19% for Q1 2026 at Rapid Micro Biosystems, down from 77.51% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 23.8% in Q1 2022 to a low of 100.19% in Q1 2026.
• The 5-year median for Return on Capital Employed is 46.64% (2024), against an average of 51.71%.
• Across the five-year window, Return on Capital Employed sank 688 bps in 2022 and slumped 3860 bps in 2026, its largest moves.
• Rapid Micro Biosystems' Return on Capital Employed stood at 35.67% in 2022, then decreased by 24 bps to 44.25% in 2023, then slumped by 34 bps to 59.12% in 2024, then slumped by 31 bps to 77.51% in 2025, then dropped by 29 bps to 100.19% in 2026.
• The last three Return on Capital Employed figures came in at 100.19% (Q1 2026), 77.51% (Q4 2025), and 71.57% (Q3 2025), per Business Quant data.